Kristen Belmonte Slaoui Bio, Age, Height, Husband, Family, Net worth
Kristen Belmonte Slaoui Biography
This is what you need to know about Kristen Belmonte Slaoui is an American citizen she is famous for being the wife of Moncef Slaoui. Her husband is an American -Belgian -Moroccan researcher. Kristen is the vice president of GlaxoSmithKline Plc in North America and also the assistant professor at The Hopkins Bloomberg.
Kristen Belmonte Slaoui Age
Belmonte was born on July 26th, 1970 in New York City. She is 50 years old as of 2020. Kristen celebrates her birthday on July 26th of every year.
Kristen Belmonte Slaoui Height
Belmonte stands at a height of 1.72 meters tall.
Kristen Belmonte Slaoui Family
Belmonte was born and raised by her parents in America. Little is known concerning her family. More information will be updated once it is available.
Kristen Belmonte Slaoui Husband
Belmonte is married to Moncef Mohamed Saloui he is a Moroccan-born Belgian-American researcher. The two got married in March 2011 at the Lippincott House Bed and Breakfast off of Rittenhouse Square. They have two children together a son and a daughter.
Her husband is the former head of GlaxoSmithKline’s vaccines department. He has worked at the company for 30 years and retired in 2017.
Kristen Belmonte’s Children
Belmonte is a mother of two kids a son and a daughter.
Kristen Belmonte Slaoui Net worth
Belmonte has an estimated net worth of $ 5 million U.S. dollars. This is as of March 2021. She is the vice president of GlaxoSmithKline Plc in North America and also the assistant professor at The Hopkins Bloomberg.
Kristen Belmonte Slaoui Education
Belmonte got her education from Gettysburg College where she earned her Bachelor’s degree in Biology and Classical Studies. She later joined The John Hopkins Bloomberg School of Public Health. There she got her Ph.D. in Physiology.
Kristen Belmonte Slaoui Career
After her fellowship, Belmonte began her career at GlaxoSmithKline in 2000. She was the principal investigator, respiratory and inflammation drug discovery. She later left in 2005 and spent a year at Merck Research Laboratories. She returned to GSK in 2006 and was there for another four years.